Alan Fuhrman
Director of Finance/CFO at TYRA BIOSCIENCES, INC.
Net worth: 762 293 $ as of 2024-05-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Saqib Islam | M | 54 |
SpringWorks Therapeutics LLC
 SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | 7 years |
| Daniel Lynch | M | 65 |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | 8 years |
| Todd Harris | M | 44 | 6 years | |
| Sheldon Koenig | M | 58 | 4 years | |
| Freda Lewis-Hall | M | 69 |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | 7 years |
| Daniel Bensen | M | 49 | 6 years | |
| Deval Patrick | M | 67 |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | 3 years |
| Jeffrey Schwartz | M | 45 |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | 7 years |
| Stephen P. Squinto | M | 67 |
SpringWorks Therapeutics LLC
SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | 7 years |
| Clay Siegall | M | 63 |
Mirna Therapeutics, Inc.
 Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX.
Washington Biotechnology & Biomedical Association
| 4 years |
| Jake Simson | M | 38 | 4 years | |
| J. Carroll | M | 74 | 2 years | |
| Julie Hambleton | M | 66 | 4 years | |
| Marianne Andreach | F | - | - | |
| Badreddin Edris | M | 37 | 6 years | |
| Stephen Rocamboli | M | 52 | 2 years | |
| Siddarth Subramony | M | 37 | 4 years | |
| Melissa McCracken | M | 37 | 3 years | |
| Amy Conrad | F | - | - | |
| Kim Diamond | F | - | 6 years | |
| Nina Kjellson | F | 49 | 6 years | |
| Nouhad Husseini | M | - | 2 years | |
| Benjamin Looker | M | 42 | 2 years | |
| Robert Hudkins | M | 69 | 4 years | |
| Benjamin Halladay | M | 38 | 4 years | |
| Rehan Verjee | M | 43 | 3 years | |
| Ali Fawaz | M | - | 2 years | |
| Tracy Woody | F | 54 | 5 years | |
| Eric Warren | M | 76 | 3 years | |
| Nicole Vitullo | F | 66 | 16 years | |
| Antonio Gotto | M | 88 | 10 years | |
| Gilla Kaplan | M | 76 | 5 years | |
| Carlos Alban | M | 61 | 2 years | |
| Jay Shepard | M | 66 | 6 years | |
| Herschel Weinstein | M | 68 | 4 years | |
| Margaret McCormick | M | - |
Washington Biotechnology & Biomedical Association
| 17 years |
| Robert More | M | 56 | 6 years | |
| James Katzaroff | M | 66 |
Washington Biotechnology & Biomedical Association
| 13 years |
| Ralph Derrickson | M | 65 |
Washington Biotechnology & Biomedical Association
| 10 years |
| Jennifer Olsen | F | - |
Washington Biotechnology & Biomedical Association
| - |
| Claudia Mitchell | M | - |
Washington Biotechnology & Biomedical Association
| - |
| Alan Frazier | M | 72 |
Washington Biotechnology & Biomedical Association
| - |
| Richard Fabian | M | - |
Washington Biotechnology & Biomedical Association
| 4 years |
| Lauren Hackett | F | - |
Washington Biotechnology & Biomedical Association
| 4 years |
| Melissa Neal | F | - | - | |
| Piyush Patel | M | 59 | 3 years | |
| Jennifer Davis | F | - | - | |
| Ken Stuart | M | - |
Washington Biotechnology & Biomedical Association
| - |
| Alexis Callahan | M | - | - | |
| George Melko | M | - | - | |
| Mike Ruhl | M | - |
Washington Biotechnology & Biomedical Association
| - |
| Hiroomi Tada | M | - | 4 years | |
| Ronald Swanson | M | - | 5 years | |
| Rhonda F. Rhyne | F | 63 |
Washington Biotechnology & Biomedical Association
| 10 years |
| Jane Gross | M | 67 |
Washington Biotechnology & Biomedical Association
| - |
| Gregory Sessler | M | 71 |
Washington Biotechnology & Biomedical Association
| - |
| James R. Lisbakken | M | - |
Washington Biotechnology & Biomedical Association
| - |
| Rob Coppedge | M | - |
Washington Biotechnology & Biomedical Association
| 10 years |
| Matthew Stupfel | M | - |
Washington Biotechnology & Biomedical Association
| 10 years |
| David Lowrance | M | 56 |
Washington Biotechnology & Biomedical Association
| 10 years |
| Sonya F. Erickson | F | - |
Washington Biotechnology & Biomedical Association
| - |
| Erick Rabins | M | - |
Washington Biotechnology & Biomedical Association
| - |
| Thomas M. Fritz | M | - |
Washington Biotechnology & Biomedical Association
| - |
| Ron Myers | M | - |
Washington Biotechnology & Biomedical Association
| 10 years |
| Caitlin Cameron | F | - |
Washington Biotechnology & Biomedical Association
| 10 years |
| Sean MacLeod | M | - |
Washington Biotechnology & Biomedical Association
| - |
| John J. Cox | M | - |
Washington Biotechnology & Biomedical Association
| - |
| Todd Simpson | M | 63 |
Washington Biotechnology & Biomedical Association
| 7 years |
| Nicholas P. Dykstra | M | - |
Washington Biotechnology & Biomedical Association
| - |
| Amanda L. Rose | F | - |
Washington Biotechnology & Biomedical Association
| 4 years |
| Chad Robins | M | 49 |
Washington Biotechnology & Biomedical Association
| 7 years |
| Jary Krauser | M | - |
Washington Biotechnology & Biomedical Association
| 10 years |
| Francisco R. Velázquez | M | - |
Washington Biotechnology & Biomedical Association
| 10 years |
| Jonathon Norris | M | - |
Washington Biotechnology & Biomedical Association
| 10 years |
| Dennis Kroft | M | - |
Washington Biotechnology & Biomedical Association
| - |
| Mitchell Gold | M | 57 |
Washington Biotechnology & Biomedical Association
| - |
| Todd R. Patrick | M | 61 |
Washington Biotechnology & Biomedical Association
| - |
| Leen Kawas | M | 38 |
Washington Biotechnology & Biomedical Association
| - |
| Robert W. Overell | M | 69 |
Washington Biotechnology & Biomedical Association
| - |
| Robin Andrulevich | F | 58 |
Washington Biotechnology & Biomedical Association
| 7 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Josh Bilenker | M | 52 | 6 years | |
| Tim Mayleben | M | 63 | 11 years | |
| Michael Powell | M | 69 |
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | 13 years |
| David Bonita | M | 48 | 5 years | |
| Michael Martino | M | 68 |
Sonus Pharmaceuticals, Inc.
 Sonus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sonus Pharmaceuticals, Inc. engaged in the development of drugs for the treatment of cancer and related therapies. Its primary product TOCOSOL Paclitaxel, was an injectable paclitaxel emulsion for nonsmall cell lung cancer, ovarian cancer and bladder cancer. Sonus Pharmaceuticals was incorporated in 1991 and was headquartered in Bothell, WA. | 10 years |
| Dov Goldstein | M | 56 | 2 years | |
| Keith Flaherty | M | 53 | 9 years | |
| Steven Elms | M | 60 | 18 years | |
| Paul Lammers | M | 66 |
Mirna Therapeutics, Inc.
Mirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Mirna Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of microRNA-based oncology therapeutics. Its products includes miR-34, miR-215, miR-101, miR-16, and let-7. The company was founded Matthew M. Winkler in 2007 and is headquartered in Austin, TX. | 8 years |
| Alan J. Lewis | M | 78 | 1 years | |
| Faheem Hasnain | M | 65 | 4 years | |
| Barry A. Labinger | M | 60 | 3 years | |
| Alan Bash | M | 52 | - | |
| Mark E. McGovern | M | 70 | 8 years | |
| Daniel Janney | M | 58 | 9 years | |
| Jeffrey Berkowitz | M | 58 | 6 years | |
| Rick Bartram | M | 63 | 9 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 97 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Alan Fuhrman
- Personal Network
